1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Skin cancer

Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]

Awaiting development [GID-TA11025] Expected publication date: TBC

  • Project information
  • Project documents

27131-Tislelizumab-Chemotherapy-for-Oesophageal-Cancer-V1.0-MAR22-NON-CONF.pdf (nihr.ac.uk)